These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38771941)

  • 1. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes.
    Yang Z; Zhang Z; Li L; Jing Z; Ma Y; Lan T; Li Y; Lin Z; Fang W; Zhang J; Zhang J; Liang X; Wu B; Zheng Y; Zhang X
    Diabetes; 2024 Aug; 73(8):1325-1335. PubMed ID: 38771941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
    Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
    Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
    Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
    Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Cytokine-Primed Extracellular Vesicles with High PD-L1 Expression Ameliorate Type 1 Diabetes.
    Wang L; Qi C; Cao H; Zhang Y; Liu X; Qiu L; Wang H; Xu L; Wu Z; Liu J; Wang S; Kong D; Wang Y
    Small; 2023 Sep; 19(38):e2301019. PubMed ID: 37209021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
    Ben Nasr M; Tezza S; D'Addio F; Mameli C; Usuelli V; Maestroni A; Corradi D; Belletti S; Albarello L; Becchi G; Fadini GP; Schuetz C; Markmann J; Wasserfall C; Zon L; Zuccotti GV; Fiorina P
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes.
    Au KM; Medik Y; Ke Q; Tisch R; Wang AZ
    Adv Mater; 2021 Jun; 33(25):e2101253. PubMed ID: 33963786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of autoimmune diabetes by soluble galectin-1.
    Perone MJ; Bertera S; Shufesky WJ; Divito SJ; Montecalvo A; Mathers AR; Larregina AT; Pang M; Seth N; Wucherpfennig KW; Trucco M; Baum LG; Morelli AE
    J Immunol; 2009 Mar; 182(5):2641-53. PubMed ID: 19234158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.
    Filippi CM; Estes EA; Oldham JE; von Herrath MG
    J Clin Invest; 2009 Jun; 119(6):1515-23. PubMed ID: 19478458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
    Falcone M; Fousteri G
    Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.